QUADRA: A phase 2, open-label, single-arm study to evaluate niraparib in patients (pts) with relapsed ovarian cancer (ROC) who have received ≥3 prior chemotherapy regimens.
暂无分享,去创建一个
B. Monk | A. Oza | J. Berek | A. Secord | J. Chan | U. Matulonis | D. Miller | M. Azodi | G. Fleming | P. DiSilvestro | M. Geller | M. Cristea | A. W. Hendrickson | N. Cloven | Yong Li | Y. Li | K. Moore | R. Clark | D. Miller